Davenport & Co’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.37M Sell
79,520
-693
-0.9% -$21.3K 0.01% 533
2026
Q2
$2.78M Buy
+80,213
New +$2.15M 0.01% 497
2026
Q1
– Sell
-71,689
Closed -$2.33M – 1328
2025
Q4
$2.33M Sell
71,689
-508
-0.7% -$21.8K 0.01% 498
2025
Q3
$4.1M Buy
72,197
+704
+1% +$36.1K 0.02% 375
2025
Q2
$3.56M Sell
71,493
-135
-0.2% -$6.1K 0.02% 391
2025
Q1
$2.12M Buy
+71,628
New +$2.66M 0.01% 479

Other funds holding HIMS

Davenport & Co's HIMS Position: Q3 2026 in Review

Davenport & Co reduced its Hims & Hers Health (HIMS) stake by 0.86% in Q3 2026, selling an estimated $21.3K and leaving 79,520 shares worth $2.37M. The position accounts for 0.01% of the portfolio, ranked #533.

Davenport & Co first reported a position in HIMS in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.1M in Q3 2025. 231 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Davenport & Co held 79,520 shares of Hims & Hers Health worth $2.37M as of Q3 2026.
  • Davenport & Co sold 693 Hims & Hers Health shares in Q3 2026, an estimated $21.3K.
  • Hims & Hers Health made up 0.01% of Davenport & Co's portfolio in Q3 2026, its #533 holding.
  • Davenport & Co first reported a position in Hims & Hers Health in Q1 2025 and has held it in 6 quarters since.
  • Davenport & Co's Hims & Hers Health position peaked at $4.1M in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Davenport & Co's 13F filing for Q3 2026, filed 14 Oct 2026.